Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |